Main Topic Area
All Topic Areas
1 - 10 of 197 more >>
News
1 - 5 of 118 more >>
- Merck Reduces Cost Of Antiretroviral Efavirenz In Developing Countries
MedicalNewsToday - Wed, 21 Feb 2007 05:00 EST
- Washington State Gov. Gregoire Proposes Universal Health Coverage Plan
MedicalNewsToday - Mon, 12 Feb 2007 10:00 EST
- British Bird Flu Is Asian Strain Of H5N1 Virus
MedicalNewsToday - Sat, 03 Feb 2007 07:00 EST
- H5N1 Killed 2600 Poultry In England
MedicalNewsToday - Sat, 03 Feb 2007 05:00 EST
- Mercury Prevalent In Many Western Fish
MedicalNewsToday - Fri, 26 Jan 2007 10:00 EST
Clinical Trials
1 - 5 of 9 more >>
- Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
ClinicalTrials.gov Identifier: NCT00161512 - Active, not recruiting
Schizophrenia, Paranoid [F03.700.750.600]
- Memantine Augmentation in Obsessive-Compulsive Disorder
ClinicalTrials.gov Identifier: NCT00264238 - Recruiting
Obsessive-Compulsive Disorder [F03.080.600]
- Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg
ClinicalTrials.gov Identifier: NCT00533390 - Recruiting
Tuberculosis; HIV Infections
- A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects
ClinicalTrials.gov Identifier: NCT00476424 - Recruiting
HIV Infections
- A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy
ClinicalTrials.gov Identifier: NCT00362466 - Recruiting
Leukemia

Not Signed In -

